Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.
(20ALJ356)Crystal deal toy, incorporating a 3D lasering etching of a syringe, commemorating the close of healthcare-focused LYFE Capital Fund III.
(9AMF303)Custom Lucite tombstone celebrating the close of Navegar II. The fund, raised by Manila-based private equity firm Navegar, will focus on the consumer and business services sectors in the Philippines.
(20ALJ190)Crystal deal toy commemorating the launch of San Francisco-based GoodFinch Fund III.
(20ALJ462)Crystal deal toy celebrating the close by Technology Crossover Ventures of TCV XI. Their eleventh fund will focus on tech growth companies.
(20LJW304)Thin trapezoid deal toy celebrating the close of Long Ridge Equity Partners III. The fund targets opportunities in financial and business technology.
(20AKL510)Custom crystal tombstone marking the successful closing of Hillpointe Workforce Housing Partnership II.
(21AAL024)Crystal deal toy celebrating the successful close by EOS Capital Partners of its inaugural fund. The private equity firm is based in Germany.
(20AKL444)Lucite tombstone celebrating the closing of a technology and healthcare-focused fund by LLR Equity Partners.
(21LJW047)
